- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05244902
Gastric Emptying Times of Normal and Obese Children After Preoperative Clear Fluid Drinking: An Ultrasound Study
November 23, 2022 updated by: muhammet korkusuz, Karaman Training and Research Hospital
In the recent literature, pre-operative fasting times for pediatric patients are limited to one hour for clear fluids.
Studies related to gastric emptying times mostly searched for normal-weight children.
These studies have claimed that 3 mL/kg clear fluid can be allowed up to 1 hour before surgery.
There is a lack of interest in the gastric emptying time of obese pediatric patients during the preoperative period.
In addition, there is controversy about gastric emptying times of obese healthy children.
Some research committed the decrease of gastric emptying because of a high level of sensitivity to cholecystokinin, while others postulated that no change in gastric emptying time of obese children compared to normal weight.
The aim of this trial is to compare the gastric volume and gastric emptying time after ingestion of 3 mL/kg clear fluid in obese and non-obese pediatric patients in the pre-operative period.
Study Overview
Detailed Description
After receiving informed consent from the children and their families, American Society of Anesthesiologists (ASA) 1-2 pediatric patients between 6-14 years, who will recruit for elective surgery will be included for this study.
The children over 95% percentile will be accepted as obese.
After, the basal gastric volume will be calculated with the help of Ultrasonography (USG).
The children will receive oral 3 mL/kg(max 250 mL) 5% dextrose .USG evaluation will be made every 5 minutes until the gastric volume reaches the basal level.
Children reaching basal gastric volume will be accepted as suitable for the surgery.
The aim of this study is to compare the gastric volume and gastric emptying time after ingestion of 3 mL/kg clear fluid in obese and non-obese pediatric patients in the pre-operative period.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Karaman, Turkey, 70200
- Karaman Taining and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 14 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ASA physical state I or II
- Age 6 to 14 years.
- Gender: both sexes.
- Scheduled for non-Gastrointestinal Tract elective day-case surgery under general anesthesia.
Exclusion Criteria:
- Parent/ care giver refusal
- Ages < 6 or > 14 years old
- Children with gastro-esophageal reflux disease
- Renal failure
- Diabetes mellitus
- Cerebral palsy patients
- Mental retardation
- Esophageal strictures, achalasia or any intestinal disease that may impair the gastric emptying.
- Gastrointestinal system surgery and neurosurgical patients
- Emergency surgery
- Violation of the prescribed fasting times
- Refusing to drink prescribed clear fluid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Obese pediatric patient
Obese children aged 6-14 years, over 95% percentile, fasted for the night before planned surgery.
|
All the patients will receive oral 3mL/kg 5%Dextrose
|
Active Comparator: Non-obese pediatric patient
Non-obese children aged 6-14 years, between 5-85% percentile, fasted for the night before planned surgery.
|
All the patients will receive oral 3mL/kg 5%Dextrose
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastric emptying time
Time Frame: 90 minute
|
Time until the gastric volume reaches the baseline level again.
|
90 minute
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Antral cross-sectional area
Time Frame: 90 minute
|
Antral cross-Section Area (ACSA) (cm2) maximal anteroposterior diameter (D1) and longitudinal diameter (D2) will be measured with ultrasound and calculated with that mathematical formula: ACSA(cm2) = Π x D1 x D2 / 4 |
90 minute
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastric emptying half-time ( t 1/2)
Time Frame: 90 minute
|
Time required for ACSA to return to half maximum value.
|
90 minute
|
Gastric volume
Time Frame: 90 minute
|
The mathematical model will be used which was reported by Perlas and colleagues based on gastroscopic fluid assessment will be used for the calculation of gastric volume (mL) from ACSA.
GastricVolume(mL) = 27.0 + 14.6 x ACSA(cm2) -1.28 x Age(years)
|
90 minute
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Muhammet Korkusuz, MD, Karaman Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2022
Primary Completion (Actual)
August 17, 2022
Study Completion (Actual)
August 17, 2022
Study Registration Dates
First Submitted
February 8, 2022
First Submitted That Met QC Criteria
February 8, 2022
First Posted (Actual)
February 17, 2022
Study Record Updates
Last Update Posted (Actual)
November 25, 2022
Last Update Submitted That Met QC Criteria
November 23, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 08-2021/12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Emptying Time
-
Federal University of Minas GeraisUnknownGastric Emptying | Intestinal Transit TimeBrazil
-
University of AarhusMotilis,SwitzerlandCompletedGastric Emptying | Gastrointestinal Motility | Total Gastrointestinal Transit Time | Segmental Transit TimeDenmark
-
AstraZenecaCompletedFood Effect | Gastric Emptying Time | Magnetic Marker Monitoring | Gastrointestinal-transport | Small Intestinal Transit Time | Time for Colon ArrivalGermany
-
Columbia UniversityRecruiting
-
Medical University of ViennaCompleted
-
University of BergenThe Research Council of NorwayCompleted
-
Mayo ClinicCompletedGastric EmptyingUnited States
-
Air Force Military Medical University, ChinaCompleted
-
Coombe Women and Infants University HospitalCompleted
-
Kangbuk Samsung HospitalUnknown
Clinical Trials on 5% Dextrose
-
The Hospital for Sick ChildrenCompleted
-
Dokuz Eylul UniversityCukurova University; Kanuni Sultan Suleyman Training and Research Hospital; Baskent... and other collaboratorsCompletedFluid Therapy | Newborn Complication | Isotonic Dehydration | Hyponatremia of Newborn | Hypernatremia of Newborn | Sodium ChlorideTurkey
-
Lia BallyUniversity of PadovaCompletedPost-bariatric Hypoglycaemia | Roux-en-Y Gastric BypassSwitzerland
-
Hospital General de Niños Pedro de ElizaldeCompleted
-
Instituto Tecnologico y de Estudios Superiores...Tecnologico de MonterreyCompleted
-
McGill University Health Centre/Research Institute...CompletedSepsis | Gastroenteritis | Urinary Tract Infection | BronchiolitisCanada
-
Hospital General de Niños Pedro de ElizaldeCompleted
-
Ahi Evran University Education and Research HospitalCompletedLateral EpicondylitisTurkey
-
Iraqi Board of medical specialtiesCompleted